Valuation: ABL Diagnostics

Market Cap 40.17M 45.97M 37.14M 34.31M 64.61M 4.42B 65.78M 443M 174M 2.16B 173M 169M 7.44B P/E 2024
123x
P/E 2025 50x
Enterprise Value 41.11M 47.04M 38M 35.11M 66.11M 4.52B 67.31M 453M 178M 2.21B 177M 173M 7.62B EV / Sales 2024
7,098,474x
EV / Sales 2025 6,185,843x
Free-Float
2.52%
Yield 2024
2.03%
Yield 2025 3.67%
1 week-3.10%
Current month-10.07%
1 month-0.79%
3 months-11.97%
6 months-25.60%
Current year-16.67%
1 week 2.4
Extreme 2.4
2.62
1 month 2.2
Extreme 2.2
2.96
Current year 2.12
Extreme 2.12
5
1 year 2.12
Extreme 2.12
5.75
3 years 2.12
Extreme 2.12
9.7
5 years 1.99
Extreme 1.9875
26
10 years 1.28
Extreme 1.275
26
Manager TitleAgeSince
Chief Executive Officer - -
Director TitleAgeSince
Chairman - -
Director/Board Member - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
06-01
Advanced Biological Laboratories SA
SellCompany -57,692 0.3580%
05-26
Advanced Biological Laboratories SA
SellCompany -51,900 0.3221%
03-16
Advanced Biological Laboratories SA
SellCompany 54,745 0.3397%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-3.10%-54.13%-72.07% 45.8M
-2.54%-6.24%-31.94%-16.74% 160B
-4.72%-4.87%-11.12%-9.01% 107B
-1.36%-0.69%+1.79%+57.97% 59.56B
+0.35%-0.02%+43.33%+56.20% 52.51B
-1.54%-3.21%-14.58%-41.68% 42.39B
-3.41%-8.93% - - 34.31B
-3.10%+0.62%-13.25%-46.09% 29.46B
-0.22%+0.71%+59.74%-6.89% 25.41B
-3.47%-2.78%-7.25%-8.59% 21.15B
Average -2.01%-0.98%-3.05%-9.66% 53.23B
Weighted average by Cap. -2.51%-0.94%-7.19%-1.47%

Financials

2024 2025
Net sales 5.87 6.72 5.43 5.01 9.44 645.13 9.61 64.71 25.39 315.9 25.23 24.67 1.09K 7.97 9.12 7.36 6.8 12.81 875.54 13.04 87.82 34.45 428.72 34.24 33.48 1.48K
Net income 285K 326K 264K 244K 459K 31.34M 467K 3.14M 1.23M 15.35M 1.23M 1.2M 52.85M 987K 1.13M 912K 843K 1.59M 108M 1.62M 10.88M 4.27M 53.11M 4.24M 4.15M 183M
Net Debt 2.02M 2.32M 1.87M 1.73M 3.26M 222M 3.31M 22.31M 8.75M 109M 8.7M 8.51M 375M 933K 1.07M 862K 797K 1.5M 103M 1.53M 10.28M 4.03M 50.2M 4.01M 3.92M 173M
Logo ABL Diagnostics
ABL Diagnostics specializes in the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases (AIDS, viral hepatitis and tuberculosis) by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. Export accounts for 69.7% of net sales.
Employees
22
Date Price Change Volume
14/07/26 2.500 0.00% 1,587
13/07/26 €2.500 -0.79% 8,053
10/07/26 €2.520 +0.80% 2,305
09/07/26 €2.500 -1.57% 7,416
08/07/26 €2.540 -1.55% 3,611

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ABLD Stock